Search
palonosetron (Aloxi)
Tradename: Aloxi (FDA approved 2003)
Indications:
-> nausea/vomiting associated with chemotherapy
Dosage: oral form (Aloxi)
Adverse effects:
- prolongation of the QT interval
Mechanism of action:
-> 5HT3 receptor antagonist
General
anti-emetic
serotonin antagonist
Database Correlations
PUBCHEM correlations
References
Prescriber's Letter 11(2):suppl 2004